http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0297866-A3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
filingDate 1988-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1989-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0297866-A3
titleOfInvention Therapeutic agents
abstract Sustained release granules of ibuprofen comprising na homogeneous mixture of ibuprofen and a npharmaceutically acceptable polymeric material, noperable to provide a slow release of ibuprofen over a npH range from 1.0 to 7.0, the polymeric material being npresent in an amount of 5% to 25% by weight, based on nthe weight of the ibuprofen. The granules are prepared nby dissolving the ibuprofen and polymeric material in a nsolvent and evaporating the solvent. Suitable npolymeric materials include ethyl cellulose, high nviscosity hydroxy propyl methyl cellulose and ncopolymers of dimethyl aminoethyl methylacrylate and nmethacrylic acid ester. The granules may be compressed nto form sustained release tablets.
priorityDate 1987-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4389393-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0157695-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4389393-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0223590-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4369172-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426147
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23320385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22257357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426148
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672

Total number of triples: 28.